Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone plus misoprostol versus misoprostol alone for second-trimester fetal demise
ACTRN12612000884808Phase 3Completed
- Sponsor
- Emma Allanson
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mifepristone and misoprostol in stillbirth, sponsored by Emma Allanson. Primary endpoint: Induction commencement to delivery interval. Started Sep 2012; status: completed.
02
Drugs
mifepristonemisoprostol
03
Conditions
stillbirth
Beyond the preview
Go deeper on ACTRN12612000884808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000884808.